Rescheduling happened. It also didn't. Depending on who you ask — and where your business sits — federal cannabis policy either just took its biggest step forward in fifty years, or it drew a new line that leaves more operators behind than it lifts up. Recorded live on Day 1 of Cannabis Law Institute 2026 , this panel doesn't try to resolve that tension. It maps it — and it's led by four practitioners who've each spent years on a different side of the same fight: litigation, policy, regulation, and the balance sheet. More on who they are in a minute. First, here's why you'll want to press play. What They Get Into This isn't a recap of the DEA's order — it's a working session on what it actually means for the people building in this industry. Expect the panel to dig into: What Schedule III does and doesn't cover — and why "partial rescheduling" is the more accurate term The widening gap between medical and adult-use operators,...
